Skip to main content

Table 1 Resistant determinants and sources of multidrug-resistant clinical isolates of Acinetobacter baumannii

From: In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii

Isolate Properties Isolate source
AB 19606 Antibiotic Susceptible type Strain. National Collection of type cultures
AB 14 MDR PFGE defined UK OXA-23 clone 1 OXA-23-like carbapenemase producer. Dr J Turton, Public Health England, Colindale, UK
AB 16 MDR PFGE defined UK OXA-23 clone 2 OXA-23 carbapenemase producer. Dr J Turton, Public Health England, Colindale, UK
AB 186 MDR PFEG defined UK ‘burn’ strain, OXA-23 producer. Dr J Turton, Public Health England, Colindale, UK
AB 202 Tigecycline-resistant strain UK OXA-23 clone 1 isolate. Barts Health NHS Trust, London, UK
AB 205 Colistin resistant UK OXA-23 clone 1 isolate. Barts Health NHS Trust, London, UK
AB 292 MDR PFGE-defined OXA-23-like carbapenemase producer. Barts Health NHS Trust, London, UK
AB 306 MDR NDM-1 carbapenemase producer. Barts Health NHS Trust, London, UK
AB 308 MDR NDM-2 carbapenemase producer. S. Gottig, Goethe Universistat, Frankfurt, Germany